ArticleFrontiers in immunology2025

Non-neutralizing anti-type I interferon autoantibodies could increase thrombotic risk in critical COVID-19 patients.

Mario Framil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.